WASHINGTON, June 10 -- Food and Drug Administration has issued a notice called: Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information.
The notice was published in the Federal Register on June 10 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: In response to an over-the-counter (OTC) monograph order request (OMOR), the Food and Drug Administration (FDA) is announcing the availability on its website of the final administrative order (final order) (OTC000039) titled "Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information." This final order amends "Over-the-...